Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines
Abstract
Spillover of infectious diseases from wildlife populations into humans is an increasing threat to human health and welfare. Current approaches to manage these emerging infectious diseases are largely reactive, leading to deadly and costly time lags between emergence and control. Here, we use mathematical models and data from previously published experimental and field studies to evaluate the scope for a more proactive approach based on transmissible vaccines that eliminates pathogens from wild animal populations before spillover can occur. Our models are focused on transmissible vaccines designed using herpes virus vectors and demonstrate that these vaccines—currently under development for several important human pathogens—may have the potential to rapidly control zoonotic pathogens within the reservoir hosts.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 19, 2022
- Source ID
- 10.1073/pnas.2108610119
Entities
People
- Alec J Redwood
- Andrew J Basinski
- Christopher H. Remien
- Scott L Nuismer
- Shelley Gorman
- Tanner J. Varrelman
Organizations
- National Institutes of Health
- University of Idaho
- University of Western Australia